These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29675257)

  • 21. Subjective health status in Norwegian patients with Addison's disease.
    Løvås K; Loge JH; Husebye ES
    Clin Endocrinol (Oxf); 2002 May; 56(5):581-8. PubMed ID: 12030907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of hypoadrenocorticism (Addison's disease) in dogs.
    Lathan P; Thompson AL
    Vet Med (Auckl); 2018; 9():1-10. PubMed ID: 30050862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Akinetic mutism followed by a manic reaction on introduction of steroid replacement for Addison's disease.
    Kalambokis G; Konitsiotis S; Pappas D; Tsianos EV
    J Endocrinol Invest; 2006 Mar; 29(3):257-60. PubMed ID: 16682841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Profile of Addison's Disease in a Tertiary Care Institute, Southern India - The Changing Landscape.
    Sridhar S; Balachandran K; Nazirudeen R; Natarajan V; Sangumani J
    Indian J Endocrinol Metab; 2022; 26(1):50-54. PubMed ID: 35662761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adrenal crisis and mortality rate in adrenal insufficiency and congenital adrenal hyperplasia.
    Lousada LM; Mendonca BB; Bachega TASS
    Arch Endocrinol Metab; 2021 Nov; 65(4):488-494. PubMed ID: 34283908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe hyponatraemia with absence of hyperkalaemia in rapidly progressive Addison's disease.
    Thompson MD; Kalmar E; Bowden SA
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 26021383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addison's disease as a primary manifestation of extrapulmonary tuberculosis; A case report.
    Ranawaka N; Welikumbura NH
    Indian J Tuberc; 2021 Jul; 68(3):405-407. PubMed ID: 34099210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.
    Camozzi V; Betterle C; Frigo AC; Zaccariotto V; Zaninotto M; De Caneva E; Lucato P; Gomiero W; Garelli S; Sabbadin C; Salvà M; Costa MD; Boscaro M; Luisetto G
    Endocrine; 2018 Feb; 59(2):319-329. PubMed ID: 28795340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneous natural history of Addison's disease: mineralocorticoid deficiency may predominate.
    Howarth S; Giovanelli L; Napier C; Pearce SH
    Endocr Connect; 2023 Jan; 12(1):. PubMed ID: 36398876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The acute effect of a mineralocorticoid receptor agonist on corticotrope secretion in Addison's disease.
    Berardelli R; Karamouzis I; D'Angelo V; Fussotto B; Minetto MA; Ghigo E; Giordano R; Arvat E
    J Endocrinol Invest; 2016 May; 39(5):537-42. PubMed ID: 26450146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoid replacement therapy in patients with Addison's disease.
    Kyriazopoulou V
    Expert Opin Pharmacother; 2007 Apr; 8(6):725-9. PubMed ID: 17425469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replacement therapy for Addison's disease: recent developments.
    Løvås K; Husebye ES
    Expert Opin Investig Drugs; 2008 Apr; 17(4):497-509. PubMed ID: 18363515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addison's disease presenting as acute chest syndrome: case report and review of literature.
    Akpa MR; Odia OJ
    Niger J Med; 2006; 15(4):451-2. PubMed ID: 17111738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current and emerging therapies for Addison's disease.
    Napier C; Pearce SH
    Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):147-53. PubMed ID: 24755997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploration of knowledge and understanding in patients with primary adrenal insufficiency: a mixed methods study.
    Shepherd LM; Tahrani AA; Inman C; Arlt W; Carrick-Sen DM
    BMC Endocr Disord; 2017 Aug; 17(1):47. PubMed ID: 28764794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune Addison's disease.
    Napier C; Pearce SH
    Presse Med; 2012 Dec; 41(12 P 2):e626-35. PubMed ID: 23177474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salivary cortisol day curves in assessing glucocorticoid replacement therapy in Addison's disease.
    Smans L; Lentjes E; Hermus A; Zelissen P
    Hormones (Athens); 2013; 12(1):93-100. PubMed ID: 23624135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent hypoglycaemia in type-1 diabetes mellitus may unravel the association with Addison's disease: a case report.
    Passanisi S; Timpanaro T; Lo Presti D; Caruso-Nicoletti M
    BMC Res Notes; 2014 Sep; 7():634. PubMed ID: 25214204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Residual adrenal function in autoimmune Addison's disease: improvement after tetracosactide (ACTH1-24) treatment.
    Gan EH; MacArthur K; Mitchell AL; Hughes BA; Perros P; Ball SG; James RA; Quinton R; Chen S; Furmaniak J; Arlt W; Pearce SH
    J Clin Endocrinol Metab; 2014 Jan; 99(1):111-8. PubMed ID: 24170102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardiovascular and metabolic impact of glucocorticoid substitution therapy in patients with Addison's disease].
    Salah DB; Charfi N; Elleuch M; Kacem FH; Rekik N; Mnif M; Mnif F; Abid M
    Pan Afr Med J; 2018; 30():251. PubMed ID: 30627312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.